G1 Therapeutics Inc. (GTHX) NASDAQ
$4.32 (0.15) (-3.36%)
Market Cap: $233.33M
As of 03/28/24 04:00 PM EDT. Market closed.
G1 Therapeutics Inc. (GTHX)
NASDAQ
$4.32
(0.15) (-3.36%)
Market Cap: $233.33M
As of 03/28/24 04:00 PM EDT. Market closed.
g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug ... read more
g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Umstead John W. V | Chief Financial Officer | Mar 18, 2024 | Sale | $3.02 | 6,547 | 19,752 | 123,896 | Mar 20, 2024, 04:32 PM |
Malik Rajesh | Chief Medical Officer | Feb 12, 2024 | Option Exercise | $0.30 | 28,600 | 8,580 | 198,538 | Feb 13, 2024, 06:14 PM |
Malik Rajesh | Chief Medical Officer | Feb 12, 2024 | Sale | $4.62 | 28,600 | 132,143 | 169,938 | Feb 13, 2024, 06:14 PM |
Umstead John W. V | Chief Financial Officer | Jan 04, 2024 | Sale | $2.94 | 111 | 327 | 130,443 | Jan 08, 2024, 06:04 AM |
Umstead John W. V | Chief Financial Officer | Jan 03, 2024 | Sale | $3.12 | 632 | 1,971 | 130,933 | Jan 08, 2024, 06:04 AM |
Malik Rajesh | Chief Medical Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 169,938 | Jan 08, 2024, 06:03 AM |
Malik Rajesh | Chief Medical Officer | Jan 03, 2024 | Sale | $3.12 | 3,019 | 9,416 | 172,920 | Jan 08, 2024, 06:03 AM |
Perry Andrew | Chief Commercial Officer | Jan 03, 2024 | Sale | $3.12 | 2,413 | 7,526 | 89,136 | Jan 08, 2024, 06:03 AM |
Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2024 | Sale | $3.12 | 11,686 | 36,447 | 498,688 | Jan 08, 2024, 06:02 AM |
Avagliano Mark | Chief Business Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 117,834 | Jan 08, 2024, 06:02 AM |
Avagliano Mark | Chief Business Officer | Jan 03, 2024 | Sale | $3.12 | 3,360 | 10,480 | 121,157 | Jan 08, 2024, 06:02 AM |
MURDOCK TERRY L | Chief Operating Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 103,638 | Jan 08, 2024, 06:00 AM |
MURDOCK TERRY L | Chief Operating Officer | Jan 03, 2024 | Sale | $3.12 | 3,019 | 9,416 | 106,620 | Jan 08, 2024, 06:00 AM |
Bailey John E. (Jack) Jr. | President and CEO | Jan 02, 2024 | Sale | $3.27 | 32,983 | 108,006 | 400,580 | Jan 02, 2024, 07:44 PM |
Malik Rajesh | Chief Medical Officer | Dec 11, 2023 | Option Exercise | $0.36 | 33,839 | 12,081 | 157,817 | Dec 13, 2023, 04:45 PM |
Malik Rajesh | Chief Medical Officer | Dec 11, 2023 | Sale | $3.41 | 33,839 | 115,522 | 136,378 | Dec 13, 2023, 04:45 PM |
Velleca Mark A. | Director | Aug 08, 2023 | Option Exercise | $0.39 | 60,000 | 23,156 | 173,286 | Aug 10, 2023, 04:11 PM |
Velleca Mark A. | Director | Aug 08, 2023 | Sale | $2.00 | 60,000 | 119,974 | 116,000 | Aug 10, 2023, 04:11 PM |
Perry Andrew | Chief Commercial Officer | Jul 05, 2023 | Sale | $2.45 | 355 | 871 | 55,945 | Jul 07, 2023, 04:08 PM |
MURDOCK TERRY L | Chief Operating Officer | Jul 05, 2023 | Sale | $2.45 | 1,361 | 3,339 | 70,078 | Jul 07, 2023, 04:08 PM |
Malik Rajesh | Chief Medical Officer | Jul 05, 2023 | Sale | $2.45 | 1,361 | 3,339 | 136,378 | Jul 07, 2023, 04:08 PM |
Bailey John E. (Jack) Jr. | President and CEO | Jul 05, 2023 | Sale | $2.45 | 2,719 | 6,672 | 433,563 | Jul 07, 2023, 04:07 PM |
Moses Jennifer K. | CFO | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 57,820 | Jan 05, 2023, 08:26 PM |
Moses Jennifer K. | CFO | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 58,549 | Jan 05, 2023, 08:26 PM |
MURDOCK TERRY L | Chief Operating Officer | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 36,439 | Jan 05, 2023, 08:26 PM |
MURDOCK TERRY L | Chief Operating Officer | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 37,168 | Jan 05, 2023, 08:26 PM |
Perry Andrew | Chief Commercial Officer | Jan 04, 2023 | Sale | $5.58 | 820 | 4,572 | 21,300 | Jan 05, 2023, 08:25 PM |
Malik Rajesh | Chief Medical Officer | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 102,739 | Jan 05, 2023, 08:25 PM |
Malik Rajesh | Chief Medical Officer | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 103,468 | Jan 05, 2023, 08:25 PM |
Hanson James S. | General Counsel | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 41,087 | Jan 05, 2023, 08:25 PM |
Hanson James S. | General Counsel | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 41,816 | Jan 05, 2023, 08:25 PM |
Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2023 | Sale | $5.85 | 32,019 | 187,452 | 281,889 | Jan 05, 2023, 08:23 PM |
Bailey John E. (Jack) Jr. | President and CEO | Jan 04, 2023 | Sale | $5.58 | 5,607 | 31,262 | 276,282 | Jan 05, 2023, 08:23 PM |
Malik Rajesh | Chief Medical Officer | Dec 15, 2022 | Option Exercise | $0.30 | 14,000 | 4,200 | 87,207 | Dec 16, 2022, 04:12 PM |
Velleca Mark A. | Director | Oct 18, 2022 | Option Exercise | $0.39 | 15,000 | 5,850 | 131,000 | Oct 20, 2022, 04:05 PM |
Velleca Mark A. | Director | Oct 18, 2022 | Sale | $11.70 | 15,000 | 175,489 | 116,000 | Oct 20, 2022, 04:05 PM |
Velleca Mark A. | Director | Sep 20, 2022 | Option Exercise | $0.39 | 20,000 | 7,800 | 136,000 | Sep 22, 2022, 04:40 PM |
Velleca Mark A. | Director | Sep 20, 2022 | Sale | $13.50 | 20,000 | 270,044 | 116,000 | Sep 22, 2022, 04:40 PM |
Malik Rajesh | Chief Medical Officer | Sep 13, 2022 | Option Exercise | $0.39 | 18,000 | 7,020 | 91,207 | Sep 16, 2022, 04:31 PM |
Malik Rajesh | Chief Medical Officer | Sep 13, 2022 | Sale | $15.71 | 18,000 | 282,746 | 73,207 | Sep 16, 2022, 04:31 PM |
Velleca Mark A. | Director | Aug 16, 2022 | Option Exercise | $0.39 | 80,000 | 31,200 | 196,000 | Aug 18, 2022, 04:06 PM |
Velleca Mark A. | Director | Aug 16, 2022 | Sale | $12.64 | 80,000 | 1,010,904 | 116,000 | Aug 18, 2022, 04:06 PM |
Velleca Mark A. | Director | Feb 07, 2022 | Option Exercise | $0.39 | 15,000 | 5,850 | 116,000 | Feb 08, 2022, 04:05 PM |
Moses Jennifer K. | CFO | Feb 01, 2022 | Option Exercise | $4.11 | 2,333 | 9,579 | 37,888 | Feb 02, 2022, 05:20 PM |
Malik Rajesh | Chief Medical Officer | Feb 01, 2022 | Option Exercise | $0.30 | 10,000 | 3,000 | 73,855 | Feb 02, 2022, 05:20 PM |
Hanson James S. | General Counsel | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 25,555 | Jan 05, 2022, 08:48 PM |
MURDOCK TERRY L | Chief Operating Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 21,555 | Jan 05, 2022, 08:25 PM |
Moses Jennifer K. | CFO | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 35,555 | Jan 05, 2022, 08:25 PM |
Malik Rajesh | Chief Medical Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 63,855 | Jan 05, 2022, 08:24 PM |
Avagliano Mark | Chief Business Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 21,555 | Jan 05, 2022, 08:24 PM |
Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2022 | Sale | $10.41 | 34,125 | 355,262 | 233,208 | Jan 05, 2022, 08:24 PM |
Velleca Mark A. | Director | Nov 09, 2021 | Option Exercise | $0.39 | 40,000 | 15,600 | 101,000 | Nov 10, 2021, 04:05 PM |
Velleca Mark A. | Director | Jul 15, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jul 15, 2021, 04:01 PM |
Velleca Mark A. | Director | Jul 14, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jul 15, 2021, 04:01 PM |
Velleca Mark A. | Director | Jul 13, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jul 15, 2021, 04:01 PM |
Velleca Mark A. | Director | Jul 15, 2021 | Sale | $18.49 | 10,000 | 184,898 | 61,000 | Jul 15, 2021, 04:01 PM |
Velleca Mark A. | Director | Jul 14, 2021 | Sale | $19.08 | 10,000 | 190,824 | 61,000 | Jul 15, 2021, 04:01 PM |
Velleca Mark A. | Director | Jul 13, 2021 | Sale | $19.45 | 10,000 | 194,536 | 61,000 | Jul 15, 2021, 04:01 PM |
RUDNICK SETH | Director | Jun 29, 2021 | Option Exercise | $0.37 | 10,000 | 3,717 | 14,389 | Jun 30, 2021, 04:05 PM |
RUDNICK SETH | Director | Jun 29, 2021 | Sale | $22.35 | 10,000 | 223,477 | 4,389 | Jun 30, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 15, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 17, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 16, 2021 | Option Exercise | $0.39 | 10,000 | 3,900 | 71,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 17, 2021 | Sale | $21.77 | 10,000 | 217,728 | 61,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 16, 2021 | Sale | $21.74 | 10,000 | 217,384 | 61,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | Jun 15, 2021 | Sale | $22.39 | 10,000 | 223,909 | 61,000 | Jun 17, 2021, 04:05 PM |
Velleca Mark A. | Director | May 25, 2021 | Option Exercise | $0.39 | 20,000 | 7,800 | 61,000 | May 25, 2021, 06:29 PM |
Malik Rajesh | Chief Medical Officer | Apr 22, 2021 | Option Exercise | $0.39 | 15,000 | 5,850 | 58,300 | Apr 23, 2021, 04:39 PM |
Malik Rajesh | Chief Medical Officer | Apr 22, 2021 | Sale | $22.07 | 15,000 | 331,099 | 43,300 | Apr 23, 2021, 04:39 PM |
Malik Rajesh | Chief Medical Officer | Mar 23, 2021 | Option Exercise | $0.39 | 15,000 | 5,850 | 58,300 | Mar 24, 2021, 04:47 PM |
Malik Rajesh | Chief Medical Officer | Mar 23, 2021 | Sale | $21.94 | 15,000 | 329,059 | 43,300 | Mar 24, 2021, 04:47 PM |
Malik Rajesh | Chief Medical Officer | Mar 02, 2021 | Option Exercise | $1.55 | 15,000 | 23,219 | 58,300 | Mar 04, 2021, 05:10 PM |
Malik Rajesh | Chief Medical Officer | Mar 02, 2021 | Sale | $22.95 | 15,000 | 344,192 | 43,300 | Mar 04, 2021, 05:10 PM |
Moses Jennifer K. | CFO | Mar 03, 2021 | Option Exercise | $3.72 | 3,000 | 11,160 | 25,000 | Mar 04, 2021, 04:54 PM |
Velleca Mark A. | Director | Feb 16, 2021 | Option Exercise | $3.72 | 11,040 | 41,069 | 52,040 | Feb 18, 2021, 05:49 PM |
Velleca Mark A. | Director | Feb 18, 2021 | Option Exercise | $3.72 | 10,000 | 37,200 | 51,000 | Feb 18, 2021, 05:49 PM |
Velleca Mark A. | Director | Feb 17, 2021 | Option Exercise | $3.72 | 10,000 | 37,200 | 51,000 | Feb 18, 2021, 05:49 PM |
Velleca Mark A. | Director | Feb 16, 2021 | Sale | $35.20 | 11,040 | 388,653 | 43,723 | Feb 18, 2021, 05:49 PM |
Velleca Mark A. | Director | Feb 18, 2021 | Sale | $26.02 | 10,000 | 260,152 | 41,000 | Feb 18, 2021, 05:49 PM |
Velleca Mark A. | Director | Feb 17, 2021 | Sale | $27.64 | 10,000 | 276,433 | 41,600 | Feb 18, 2021, 05:49 PM |
Malik Rajesh | Chief Medical Officer | Jan 27, 2021 | Option Exercise | $0.39 | 3,100 | 1,209 | 43,300 | Jan 29, 2021, 04:07 PM |
Malik Rajesh | Chief Medical Officer | Jan 22, 2021 | Option Exercise | $4.17 | 15,000 | 62,550 | 55,200 | Jan 22, 2021, 06:47 PM |
Malik Rajesh | Chief Medical Officer | Jan 22, 2021 | Sale | $20.64 | 15,000 | 309,591 | 40,200 | Jan 22, 2021, 06:47 PM |
Velleca Mark A. | Director | Jan 21, 2021 | Option Exercise | $3.72 | 10,000 | 37,200 | 51,000 | Jan 21, 2021, 05:31 PM |
Velleca Mark A. | Director | Jan 20, 2021 | Option Exercise | $2.77 | 14,000 | 38,760 | 47,000 | Jan 21, 2021, 05:31 PM |
Velleca Mark A. | Director | Jan 19, 2021 | Option Exercise | $3.72 | 10,000 | 37,200 | 47,000 | Jan 21, 2021, 05:31 PM |
Velleca Mark A. | Director | Jan 20, 2021 | Sale | $21.51 | 10,000 | 215,107 | 37,000 | Jan 21, 2021, 05:31 PM |
Velleca Mark A. | Director | Jan 19, 2021 | Sale | $20.88 | 10,000 | 208,781 | 37,000 | Jan 21, 2021, 05:31 PM |
Velleca Mark A. | Director | Jan 21, 2021 | Sale | $20.64 | 10,000 | 206,400 | 41,000 | Jan 21, 2021, 05:31 PM |
RUDNICK SETH | Director | Dec 24, 2020 | Sale | $20.10 | 924 | 18,572 | 5,266 | Dec 29, 2020, 04:50 PM |
RUDNICK SETH | Director | Dec 23, 2020 | Sale | $20.18 | 13,118 | 264,757 | 6,190 | Dec 23, 2020, 06:54 PM |
RUDNICK SETH | Director | Dec 22, 2020 | Sale | $20.33 | 18,974 | 385,702 | 19,308 | Dec 23, 2020, 06:54 PM |
Velleca Mark A. | President and CEO | Dec 15, 2020 | Option Exercise | $3.72 | 10,000 | 37,200 | 47,000 | Dec 17, 2020, 06:01 PM |
Velleca Mark A. | President and CEO | Dec 17, 2020 | Option Exercise | $3.72 | 10,000 | 37,200 | 47,000 | Dec 17, 2020, 06:01 PM |
Velleca Mark A. | President and CEO | Dec 16, 2020 | Option Exercise | $3.72 | 10,000 | 37,200 | 47,000 | Dec 17, 2020, 06:01 PM |
Velleca Mark A. | President and CEO | Dec 17, 2020 | Sale | $19.97 | 10,000 | 199,668 | 37,000 | Dec 17, 2020, 06:01 PM |
Velleca Mark A. | President and CEO | Dec 16, 2020 | Sale | $19.20 | 10,000 | 192,021 | 37,000 | Dec 17, 2020, 06:01 PM |
Velleca Mark A. | President and CEO | Dec 15, 2020 | Sale | $19.43 | 10,000 | 194,297 | 37,000 | Dec 17, 2020, 06:01 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 10, 2020 | Option Exercise | $4.17 | 9,000 | 37,530 | 38,200 | Dec 11, 2020, 04:50 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 10, 2020 | Sale | $20.06 | 9,000 | 180,550 | 29,200 | Dec 11, 2020, 04:50 PM |
RUDNICK SETH | Director | Dec 10, 2020 | Sale | $20.00 | 546 | 10,921 | 38,282 | Dec 10, 2020, 05:30 PM |
RUDNICK SETH | Director | Dec 09, 2020 | Sale | $20.32 | 5,773 | 117,284 | 38,828 | Dec 10, 2020, 05:30 PM |
RUDNICK SETH | Director | Dec 08, 2020 | Sale | $20.19 | 13,161 | 265,694 | 44,601 | Dec 10, 2020, 05:30 PM |
RUDNICK SETH | Director | Dec 01, 2020 | Sale | $20.09 | 520 | 10,449 | 57,762 | Dec 03, 2020, 04:20 PM |
MUIR GLENN P | Director | Nov 18, 2020 | Buy | $13.50 | 50,000 | 675,000 | 170,969 | Nov 19, 2020, 04:54 PM |
Bailey John E. (Jack) Jr. | Director | Nov 11, 2020 | Buy | $12.83 | 4,000 | 51,320 | 8,000 | Nov 13, 2020, 04:33 PM |
Bailey John E. (Jack) Jr. | Director | Nov 10, 2020 | Buy | $12.76 | 4,000 | 51,055 | 4,000 | Nov 13, 2020, 04:33 PM |
Hanson James S. | General Counsel | Sep 04, 2020 | Buy | $14.95 | 1,000 | 14,950 | 4,000 | Sep 08, 2020, 08:38 PM |
Moses Jennifer K. | CFO | Mar 13, 2020 | Option Exercise | $3.72 | 2,000 | 7,440 | 11,000 | Mar 16, 2020, 07:00 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Mar 13, 2020 | Option Exercise | $0.39 | 2,500 | 975 | 29,200 | Mar 16, 2020, 07:00 AM |
Velleca Mark A. | President and CEO | Mar 13, 2020 | Option Exercise | $0.39 | 3,000 | 1,170 | 37,000 | Mar 16, 2020, 07:00 AM |
Velleca Mark A. | President and CEO | Jan 23, 2020 | Option Exercise | $0.39 | 6,000 | 2,340 | 34,000 | Jan 24, 2020, 04:59 PM |
Moses Jennifer K. | CFO | Jan 23, 2020 | Option Exercise | $3.72 | 1,000 | 3,720 | 9,000 | Jan 24, 2020, 04:58 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 23, 2020 | Option Exercise | $0.39 | 5,000 | 1,950 | 26,700 | Jan 24, 2020, 04:58 PM |
Moses Jennifer K. | CFO | Jul 18, 2019 | Option Exercise | $3.72 | 2,000 | 7,440 | 8,000 | Jul 19, 2019, 09:58 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 28, 2019 | Option Exercise | $0.39 | 7,000 | 2,730 | 21,700 | Jan 28, 2019, 09:10 PM |
Moses Jennifer K. | VP of Finance | Jan 17, 2019 | Option Exercise | $3.72 | 2,000 | 7,440 | 6,000 | Jan 17, 2019, 05:52 PM |
Velleca Mark A. | President and CEO | Jan 17, 2019 | Option Exercise | $0.39 | 9,000 | 3,510 | 28,000 | Jan 17, 2019, 05:52 PM |
Strum Jay | Chief Scientific Officer | Jan 02, 2019 | Option Exercise | $0.35 | 79,818 | 27,575 | 129,237 | Jan 02, 2019, 05:46 PM |
Hanson James S. | General Counsel | Dec 26, 2018 | Buy | $18.25 | 1,000 | 18,250 | 3,000 | Dec 27, 2018, 04:59 PM |
Schwalm Cynthia | Director | Dec 26, 2018 | Buy | $18.45 | 1,420 | 26,196 | 1,500 | Dec 27, 2018, 04:59 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 17, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 18,476 | Dec 17, 2018, 04:27 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 17, 2018 | Sale | $30.00 | 3,776 | 113,280 | 14,700 | Dec 17, 2018, 04:27 PM |
Hanson James S. | General Counsel | Dec 10, 2018 | Buy | $32.51 | 1,000 | 32,508 | 2,000 | Dec 11, 2018, 04:08 PM |
DEMAREE JOHN | Chief Commercial Officer | Dec 10, 2018 | Buy | $33.15 | 1,000 | 33,151 | 5,250 | Dec 11, 2018, 04:08 PM |
Moses Jennifer K. | VP of Finance & Admin | Dec 06, 2018 | Option Exercise | $0.39 | 750 | 292 | 2,750 | Dec 07, 2018, 04:07 PM |
Moses Jennifer K. | VP of Finance & Admin | Dec 07, 2018 | Option Exercise | $3.72 | 2,000 | 7,440 | 4,000 | Dec 07, 2018, 04:07 PM |
Moses Jennifer K. | VP of Finance & Admin | Dec 06, 2018 | Sale | $34.00 | 750 | 25,500 | 2,000 | Dec 07, 2018, 04:07 PM |
RUDNICK SETH | Director | Dec 04, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | Dec 04, 2018, 06:10 PM |
RUDNICK SETH | Director | Dec 04, 2018 | Sale | $39.31 | 10,000 | 393,146 | 116 | Dec 04, 2018, 06:10 PM |
MURDOCK TERRY L | SVP of Development Operations | Dec 03, 2018 | Option Exercise | $13.51 | 3,523 | 47,596 | 3,523 | Dec 03, 2018, 06:25 PM |
MURDOCK TERRY L | SVP of Development Operations | Dec 03, 2018 | Sale | $38.54 | 3,523 | 135,779 | 0 | Dec 03, 2018, 06:25 PM |
PHILLIPS BARCLAY A | SVP & Chief Financial Officer | Nov 15, 2018 | Option Exercise | $19.46 | 5,000 | 97,300 | 5,000 | Nov 16, 2018, 07:16 PM |
PHILLIPS BARCLAY A | SVP & Chief Financial Officer | Nov 15, 2018 | Sale | $39.92 | 5,000 | 199,591 | 0 | Nov 16, 2018, 07:16 PM |
Velleca Mark A. | President and CEO | Nov 15, 2018 | Option Exercise | $3.72 | 5,000 | 18,600 | 24,000 | Nov 16, 2018, 05:17 PM |
Velleca Mark A. | President and CEO | Nov 15, 2018 | Sale | $39.84 | 5,000 | 199,211 | 19,015 | Nov 16, 2018, 05:17 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Nov 15, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 18,476 | Nov 16, 2018, 05:17 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Nov 15, 2018 | Sale | $39.75 | 3,776 | 150,105 | 14,947 | Nov 16, 2018, 05:17 PM |
RUDNICK SETH | Director | Nov 05, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | Nov 07, 2018, 06:18 PM |
RUDNICK SETH | Director | Nov 05, 2018 | Sale | $41.53 | 10,000 | 415,347 | 0 | Nov 07, 2018, 06:18 PM |
MURDOCK TERRY L | SVP of Development Operations | Nov 05, 2018 | Option Exercise | $13.51 | 3,519 | 47,542 | 3,519 | Nov 07, 2018, 06:18 PM |
MURDOCK TERRY L | SVP of Development Operations | Nov 05, 2018 | Sale | $41.53 | 3,519 | 146,129 | 0 | Nov 07, 2018, 06:18 PM |
Moses Jennifer K. | VP of Finance & Admin | Nov 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 2,750 | Nov 07, 2018, 06:15 PM |
Moses Jennifer K. | VP of Finance & Admin | Nov 05, 2018 | Sale | $41.38 | 750 | 31,035 | 2,000 | Nov 07, 2018, 06:15 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Oct 15, 2018 | Option Exercise | $1.81 | 10,076 | 18,203 | 14,700 | Oct 15, 2018, 05:57 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Oct 15, 2018 | Sale | $41.71 | 3,776 | 157,497 | 11,233 | Oct 15, 2018, 05:57 PM |
Velleca Mark A. | President and CEO | Oct 15, 2018 | Option Exercise | $3.72 | 5,000 | 18,600 | 24,000 | Oct 15, 2018, 05:54 PM |
Velleca Mark A. | President and CEO | Oct 11, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 19,000 | Oct 15, 2018, 05:54 PM |
Velleca Mark A. | President and CEO | Oct 15, 2018 | Sale | $41.53 | 5,000 | 207,645 | 21,837 | Oct 15, 2018, 05:54 PM |
Moses Jennifer K. | VP of Finance & Admin | Oct 08, 2018 | Option Exercise | $0.39 | 750 | 292 | 2,750 | Oct 10, 2018, 04:45 PM |
Moses Jennifer K. | VP of Finance & Admin | Oct 08, 2018 | Sale | $44.52 | 750 | 33,390 | 2,000 | Oct 10, 2018, 04:45 PM |
Strum Jay | Chief Scientific Officer | Oct 04, 2018 | Option Exercise | $0.30 | 850 | 255 | 49,419 | Oct 05, 2018, 06:04 PM |
RUDNICK SETH | Director | Oct 04, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | Oct 05, 2018, 06:02 PM |
RUDNICK SETH | Director | Oct 04, 2018 | Sale | $49.72 | 10,000 | 497,210 | 1,980 | Oct 05, 2018, 06:02 PM |
MURDOCK TERRY L | SVP of Development Operations | Oct 03, 2018 | Option Exercise | $13.51 | 3,519 | 47,542 | 3,519 | Oct 05, 2018, 06:02 PM |
MURDOCK TERRY L | SVP of Development Operations | Oct 03, 2018 | Sale | $49.18 | 3,519 | 173,064 | 0 | Oct 05, 2018, 06:02 PM |
Velleca Mark A. | President and CEO | Sep 17, 2018 | Option Exercise | $3.72 | 5,000 | 18,600 | 14,000 | Sep 19, 2018, 07:08 PM |
Velleca Mark A. | President and CEO | Sep 17, 2018 | Sale | $66.31 | 5,000 | 331,549 | 11,165 | Sep 19, 2018, 07:08 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Sep 17, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 12,176 | Sep 19, 2018, 07:07 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Sep 17, 2018 | Sale | $66.08 | 3,776 | 249,502 | 9,184 | Sep 19, 2018, 07:07 PM |
Moses Jennifer K. | VP of Finance & Admin | Sep 05, 2018 | Option Exercise | $2.81 | 2,750 | 7,733 | 2,000 | Sep 06, 2018, 04:07 PM |
Moses Jennifer K. | VP of Finance & Admin | Sep 05, 2018 | Sale | $59.60 | 750 | 44,700 | 0 | Sep 06, 2018, 04:07 PM |
RUDNICK SETH | Director | Sep 04, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | Sep 06, 2018, 04:07 PM |
RUDNICK SETH | Director | Sep 04, 2018 | Sale | $59.95 | 10,000 | 599,483 | 500 | Sep 06, 2018, 04:07 PM |
MURDOCK TERRY L | SVP of Development Operations | Sep 04, 2018 | Option Exercise | $13.51 | 3,519 | 47,542 | 3,519 | Sep 06, 2018, 04:06 PM |
MURDOCK TERRY L | SVP of Development Operations | Sep 04, 2018 | Sale | $59.98 | 3,519 | 211,065 | 0 | Sep 06, 2018, 04:06 PM |
Strum Jay | Chief Scientific Officer | Aug 30, 2018 | Sale | $59.98 | 5,000 | 299,876 | 53,069 | Aug 31, 2018, 04:20 PM |
Strum Jay | Chief Scientific Officer | Aug 29, 2018 | Sale | $59.22 | 5,000 | 296,095 | 57,969 | Aug 31, 2018, 04:20 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Aug 15, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 12,176 | Aug 17, 2018, 03:00 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Aug 15, 2018 | Sale | $55.89 | 3,776 | 211,023 | 10,100 | Aug 17, 2018, 03:00 PM |
Velleca Mark A. | President and CEO | Aug 15, 2018 | Option Exercise | $3.72 | 5,000 | 18,600 | 14,000 | Aug 17, 2018, 02:59 PM |
Velleca Mark A. | President and CEO | Aug 15, 2018 | Sale | $55.88 | 5,000 | 279,378 | 11,301 | Aug 17, 2018, 02:59 PM |
RUDNICK SETH | Director | Aug 06, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | Aug 06, 2018, 06:19 PM |
RUDNICK SETH | Director | Aug 06, 2018 | Sale | $50.69 | 10,000 | 506,901 | 0 | Aug 06, 2018, 06:19 PM |
Moses Jennifer K. | VP of Finance & Admin | Aug 06, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Aug 06, 2018, 06:18 PM |
Moses Jennifer K. | VP of Finance & Admin | Aug 06, 2018 | Sale | $50.79 | 750 | 38,093 | 0 | Aug 06, 2018, 06:18 PM |
MURDOCK TERRY L | SVP of Development Operations | Aug 03, 2018 | Option Exercise | $13.51 | 3,519 | 47,542 | 3,519 | Aug 06, 2018, 06:17 PM |
MURDOCK TERRY L | SVP of Development Operations | Aug 03, 2018 | Sale | $50.60 | 3,519 | 178,061 | 0 | Aug 06, 2018, 06:17 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jul 16, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 12,176 | Jul 17, 2018, 04:01 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jul 16, 2018 | Sale | $42.17 | 3,776 | 159,248 | 9,662 | Jul 17, 2018, 04:01 PM |
Velleca Mark A. | President and CEO | Jul 16, 2018 | Option Exercise | $3.72 | 5,000 | 18,600 | 14,000 | Jul 17, 2018, 04:01 PM |
Velleca Mark A. | President and CEO | Jul 16, 2018 | Sale | $42.06 | 5,000 | 210,313 | 10,200 | Jul 17, 2018, 04:01 PM |
Moses Jennifer K. | VP of Finance & Admin | Jul 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Jul 05, 2018, 03:21 PM |
Moses Jennifer K. | VP of Finance & Admin | Jul 05, 2018 | Sale | $45.66 | 750 | 34,245 | 0 | Jul 05, 2018, 03:21 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jun 15, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 12,176 | Jun 18, 2018, 10:19 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jun 15, 2018 | Sale | $44.31 | 3,776 | 167,326 | 8,400 | Jun 18, 2018, 10:19 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jun 08, 2018 | Option Exercise | $0.39 | 4,200 | 1,638 | 8,400 | Jun 11, 2018, 10:51 AM |
Moses Jennifer K. | VP of Finance & Admin | Jun 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Jun 05, 2018, 02:23 PM |
Moses Jennifer K. | VP of Finance & Admin | Jun 05, 2018 | Sale | $38.77 | 750 | 29,078 | 0 | Jun 05, 2018, 02:23 PM |
Thorp Clay | 10% Owner | May 30, 2018 | Sale | $48.00 | 800,000 | 38,400,000 | 3,279,421 | Jun 01, 2018, 06:22 PM |
Velleca Mark A. | President and CEO | May 31, 2018 | Option Exercise | $0.39 | 10,000 | 3,900 | 10,000 | May 31, 2018, 04:22 PM |
Thorp Clay | 10% Owner | May 22, 2018 | Sale | $50.85 | 5,900 | 300,016 | 4,038,519 | May 23, 2018, 08:46 PM |
Thorp Clay | 10% Owner | May 21, 2018 | Sale | $51.17 | 31,100 | 1,591,411 | 4,046,206 | May 23, 2018, 08:46 PM |
Thorp Clay | 10% Owner | May 23, 2018 | Sale | $50.50 | 500 | 25,250 | 4,037,737 | May 23, 2018, 08:46 PM |
Velleca Mark A. | President and CEO | May 15, 2018 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | May 16, 2018, 01:37 PM |
Velleca Mark A. | President and CEO | May 15, 2018 | Sale | $46.28 | 7,500 | 347,064 | 1,700 | May 16, 2018, 01:37 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | May 15, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 7,976 | May 16, 2018, 01:37 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | May 15, 2018 | Sale | $46.30 | 3,776 | 174,821 | 4,300 | May 16, 2018, 01:37 PM |
Moses Jennifer K. | VP of Finance & Admin | May 07, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | May 07, 2018, 03:04 PM |
Moses Jennifer K. | VP of Finance & Admin | May 07, 2018 | Sale | $45.00 | 750 | 33,750 | 0 | May 07, 2018, 03:04 PM |
Velleca Mark A. | President and CEO | Apr 16, 2018 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | Apr 17, 2018, 12:20 PM |
Velleca Mark A. | President and CEO | Apr 16, 2018 | Sale | $36.00 | 7,500 | 269,971 | 500 | Apr 17, 2018, 12:20 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Apr 16, 2018 | Option Exercise | $4.17 | 3,776 | 15,746 | 7,976 | Apr 17, 2018, 12:20 PM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Apr 16, 2018 | Sale | $36.05 | 3,776 | 136,135 | 4,700 | Apr 17, 2018, 12:20 PM |
Moses Jennifer K. | VP of Finance & Admin | Apr 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Apr 05, 2018, 04:04 PM |
Moses Jennifer K. | VP of Finance & Admin | Apr 05, 2018 | Sale | $37.47 | 750 | 28,103 | 0 | Apr 05, 2018, 04:04 PM |
Velleca Mark A. | President and CEO | Mar 15, 2018 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | Mar 16, 2018, 10:09 AM |
Velleca Mark A. | President and CEO | Mar 15, 2018 | Sale | $38.20 | 7,500 | 286,466 | 0 | Mar 16, 2018, 10:09 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Mar 15, 2018 | Option Exercise | $0.89 | 3,776 | 3,348 | 7,976 | Mar 16, 2018, 10:09 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Mar 15, 2018 | Sale | $38.18 | 3,776 | 144,151 | 4,200 | Mar 16, 2018, 10:09 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Mar 08, 2018 | Option Exercise | $0.39 | 4,200 | 1,638 | 4,200 | Mar 09, 2018, 02:36 PM |
Moses Jennifer K. | VP of Finance & Admin | Mar 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Mar 06, 2018, 04:01 PM |
Moses Jennifer K. | VP of Finance & Admin | Mar 05, 2018 | Sale | $26.55 | 750 | 19,912 | 0 | Mar 06, 2018, 04:01 PM |
Velleca Mark A. | President and CEO | Feb 15, 2018 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | Feb 16, 2018, 11:54 AM |
Velleca Mark A. | President and CEO | Feb 15, 2018 | Sale | $20.00 | 7,500 | 150,015 | 0 | Feb 16, 2018, 11:54 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Feb 15, 2018 | Option Exercise | $0.32 | 3,776 | 1,213 | 3,776 | Feb 16, 2018, 11:54 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Feb 15, 2018 | Sale | $20.00 | 3,776 | 75,520 | 0 | Feb 16, 2018, 11:54 AM |
Moses Jennifer K. | VP of Finance & Admin | Feb 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Feb 06, 2018, 11:00 AM |
Moses Jennifer K. | VP of Finance & Admin | Feb 05, 2018 | Sale | $22.99 | 750 | 17,242 | 0 | Feb 06, 2018, 11:00 AM |
Velleca Mark A. | President and CEO | Jan 16, 2018 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | Jan 17, 2018, 09:48 AM |
Velleca Mark A. | President and CEO | Jan 16, 2018 | Sale | $22.99 | 7,500 | 172,395 | 0 | Jan 17, 2018, 09:48 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 16, 2018 | Option Exercise | $0.30 | 3,776 | 1,133 | 3,776 | Jan 17, 2018, 09:47 AM |
Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 16, 2018 | Sale | $22.96 | 3,776 | 86,693 | 0 | Jan 17, 2018, 09:47 AM |
Moses Jennifer K. | VP of Finance & Admin | Jan 05, 2018 | Option Exercise | $0.39 | 750 | 292 | 750 | Jan 08, 2018, 09:42 AM |
Moses Jennifer K. | VP of Finance & Admin | Jan 05, 2018 | Sale | $19.96 | 750 | 14,970 | 0 | Jan 08, 2018, 09:42 AM |
Velleca Mark A. | President and CEO | Dec 18, 2017 | Option Exercise | $3.72 | 7,500 | 27,900 | 7,500 | Dec 20, 2017, 08:48 AM |
Velleca Mark A. | President and CEO | Dec 18, 2017 | Sale | $20.01 | 7,500 | 150,106 | 0 | Dec 20, 2017, 08:48 AM |
MedImmune Ventures, Inc. | 10% Owner | Dec 15, 2017 | Sale | $19.75 | 200,000 | 3,950,000 | 2,950,630 | Dec 18, 2017, 05:48 PM |
MedImmune Ventures, Inc. | 10% Owner | May 17, 2017 | Buy | $15.00 | 75,000 | 1,125,000 | 3,409,536 | Dec 13, 2017, 11:46 AM |
MedImmune Ventures, Inc. | 10% Owner | Dec 01, 2017 | Sale | $19.75 | 133,906 | 2,644,644 | 3,150,630 | Dec 05, 2017, 09:17 AM |
MedImmune Ventures, Inc. | 10% Owner | Nov 20, 2017 | Sale | $20.01 | 200,000 | 4,002,000 | 3,284,536 | Nov 22, 2017, 10:13 AM |
ESHELMAN FREDRIC N | Director | Nov 13, 2017 | Buy | $19.73 | 250,000 | 4,932,500 | 250,000 | Nov 15, 2017, 05:12 PM |
Eshelman Ventures, LLC | 10% Owner | May 22, 2017 | Buy | $15.00 | 300,000 | 4,500,000 | 3,439,151 | May 24, 2017, 08:29 PM |
Thorp Clay | 10% Owner | May 22, 2017 | Buy | $15.00 | 133,333 | 1,999,995 | 3,861,797 | May 24, 2017, 08:18 PM |
ESHELMAN FREDRIC N | Director | May 22, 2017 | Buy | $15.00 | 300,000 | 4,500,000 | 3,439,151 | May 24, 2017, 08:05 PM |
MUIR GLENN P | Director | May 22, 2017 | Buy | $15.00 | 20,000 | 300,000 | 120,969 | May 24, 2017, 07:58 PM |
MedImmune Ventures, Inc. | 10% Owner | May 22, 2017 | Buy | $15.00 | 75,000 | 1,125,000 | 3,484,536 | May 24, 2017, 07:57 PM |
RA CAPITAL MANAGEMENT, LLC | Fmr 10% Owner See Footnote (2) | May 22, 2017 | Buy | $15.00 | 400,000 | 6,000,000 | 2,684,244 | May 24, 2017, 04:34 PM |
Owner | Relationship | Date | Value($) |
Umstead John W. V | Chief Financial Officer | 03/18/2024 | 19,752 |
Malik Rajesh | Chief Medical Officer | 02/12/2024 | 8,580 |
Malik Rajesh | Chief Medical Officer | 02/12/2024 | 132,143 |
Umstead John W. V | Chief Financial Officer | 01/04/2024 | 327 |
Umstead John W. V | Chief Financial Officer | 01/03/2024 | 1,971 |
Malik Rajesh | Chief Medical Officer | 01/04/2024 | 2,121 |
Malik Rajesh | Chief Medical Officer | 01/03/2024 | 9,416 |
Perry Andrew | Chief Commercial Officer | 01/03/2024 | 7,526 |
Bailey John E. (Jack) Jr. | President and CEO | 01/03/2024 | 36,447 |
Avagliano Mark | Chief Business Officer | 01/04/2024 | 2,121 |
Avagliano Mark | Chief Business Officer | 01/03/2024 | 10,480 |
MURDOCK TERRY L | Chief Operating Officer | 01/04/2024 | 2,121 |
MURDOCK TERRY L | Chief Operating Officer | 01/03/2024 | 9,416 |
Bailey John E. (Jack) Jr. | President and CEO | 01/02/2024 | 108,006 |
Malik Rajesh | Chief Medical Officer | 12/11/2023 | 12,081 |
Malik Rajesh | Chief Medical Officer | 12/11/2023 | 115,522 |
Velleca Mark A. | Director | 08/08/2023 | 23,156 |
Velleca Mark A. | Director | 08/08/2023 | 119,974 |
Perry Andrew | Chief Commercial Officer | 07/05/2023 | 871 |
MURDOCK TERRY L | Chief Operating Officer | 07/05/2023 | 3,339 |
Malik Rajesh | Chief Medical Officer | 07/05/2023 | 3,339 |
Bailey John E. (Jack) Jr. | President and CEO | 07/05/2023 | 6,672 |
Moses Jennifer K. | CFO | 01/05/2023 | 3,942 |
Moses Jennifer K. | CFO | 01/04/2023 | 9,138 |
MURDOCK TERRY L | Chief Operating Officer | 01/05/2023 | 3,942 |
MURDOCK TERRY L | Chief Operating Officer | 01/04/2023 | 9,138 |
Perry Andrew | Chief Commercial Officer | 01/04/2023 | 4,572 |
Malik Rajesh | Chief Medical Officer | 01/05/2023 | 3,942 |
Malik Rajesh | Chief Medical Officer | 01/04/2023 | 9,138 |
Hanson James S. | General Counsel | 01/05/2023 | 3,942 |
Hanson James S. | General Counsel | 01/04/2023 | 9,138 |
Bailey John E. (Jack) Jr. | President and CEO | 01/03/2023 | 187,452 |
Bailey John E. (Jack) Jr. | President and CEO | 01/04/2023 | 31,262 |
Malik Rajesh | Chief Medical Officer | 12/15/2022 | 4,200 |
Velleca Mark A. | Director | 10/18/2022 | 5,850 |
Velleca Mark A. | Director | 10/18/2022 | 175,489 |
Velleca Mark A. | Director | 09/20/2022 | 7,800 |
Velleca Mark A. | Director | 09/20/2022 | 270,044 |
Malik Rajesh | Chief Medical Officer | 09/13/2022 | 7,020 |
Malik Rajesh | Chief Medical Officer | 09/13/2022 | 282,746 |
Velleca Mark A. | Director | 08/16/2022 | 31,200 |
Velleca Mark A. | Director | 08/16/2022 | 1,010,904 |
Velleca Mark A. | Director | 02/07/2022 | 5,850 |
Moses Jennifer K. | CFO | 02/01/2022 | 9,579 |
Malik Rajesh | Chief Medical Officer | 02/01/2022 | 3,000 |
Hanson James S. | General Counsel | 01/05/2022 | 15,334 |
MURDOCK TERRY L | Chief Operating Officer | 01/05/2022 | 15,334 |
Moses Jennifer K. | CFO | 01/05/2022 | 15,334 |
Malik Rajesh | Chief Medical Officer | 01/05/2022 | 15,334 |
Avagliano Mark | Chief Business Officer | 01/05/2022 | 15,334 |
Bailey John E. (Jack) Jr. | President and CEO | 01/03/2022 | 355,262 |
Velleca Mark A. | Director | 11/09/2021 | 15,600 |
Velleca Mark A. | Director | 07/15/2021 | 3,900 |
Velleca Mark A. | Director | 07/14/2021 | 3,900 |
Velleca Mark A. | Director | 07/13/2021 | 3,900 |
Velleca Mark A. | Director | 07/15/2021 | 184,898 |
Velleca Mark A. | Director | 07/14/2021 | 190,824 |
Velleca Mark A. | Director | 07/13/2021 | 194,536 |
RUDNICK SETH | Director | 06/29/2021 | 3,717 |
RUDNICK SETH | Director | 06/29/2021 | 223,477 |
Velleca Mark A. | Director | 06/15/2021 | 3,900 |
Velleca Mark A. | Director | 06/17/2021 | 3,900 |
Velleca Mark A. | Director | 06/16/2021 | 3,900 |
Velleca Mark A. | Director | 06/17/2021 | 217,728 |
Velleca Mark A. | Director | 06/16/2021 | 217,384 |
Velleca Mark A. | Director | 06/15/2021 | 223,909 |
Velleca Mark A. | Director | 05/25/2021 | 7,800 |
Malik Rajesh | Chief Medical Officer | 04/22/2021 | 5,850 |
Malik Rajesh | Chief Medical Officer | 04/22/2021 | 331,099 |
Malik Rajesh | Chief Medical Officer | 03/23/2021 | 5,850 |
Malik Rajesh | Chief Medical Officer | 03/23/2021 | 329,059 |
Malik Rajesh | Chief Medical Officer | 03/02/2021 | 23,219 |
Malik Rajesh | Chief Medical Officer | 03/02/2021 | 344,192 |
Moses Jennifer K. | CFO | 03/03/2021 | 11,160 |
Velleca Mark A. | Director | 02/16/2021 | 41,069 |
Velleca Mark A. | Director | 02/18/2021 | 37,200 |
Velleca Mark A. | Director | 02/17/2021 | 37,200 |
Velleca Mark A. | Director | 02/16/2021 | 388,653 |
Velleca Mark A. | Director | 02/18/2021 | 260,152 |
Velleca Mark A. | Director | 02/17/2021 | 276,433 |
Malik Rajesh | Chief Medical Officer | 01/27/2021 | 1,209 |
Malik Rajesh | Chief Medical Officer | 01/22/2021 | 62,550 |
Malik Rajesh | Chief Medical Officer | 01/22/2021 | 309,591 |
Velleca Mark A. | Director | 01/21/2021 | 37,200 |
Velleca Mark A. | Director | 01/20/2021 | 38,760 |
Velleca Mark A. | Director | 01/19/2021 | 37,200 |
Velleca Mark A. | Director | 01/20/2021 | 215,107 |
Velleca Mark A. | Director | 01/19/2021 | 208,781 |
Velleca Mark A. | Director | 01/21/2021 | 206,400 |
RUDNICK SETH | Director | 12/24/2020 | 18,572 |
RUDNICK SETH | Director | 12/23/2020 | 264,757 |
RUDNICK SETH | Director | 12/22/2020 | 385,702 |
Velleca Mark A. | President and CEO | 12/15/2020 | 37,200 |
Velleca Mark A. | President and CEO | 12/17/2020 | 37,200 |
Velleca Mark A. | President and CEO | 12/16/2020 | 37,200 |
Velleca Mark A. | President and CEO | 12/17/2020 | 199,668 |
Velleca Mark A. | President and CEO | 12/16/2020 | 192,021 |
Velleca Mark A. | President and CEO | 12/15/2020 | 194,297 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 12/10/2020 | 37,530 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 12/10/2020 | 180,550 |
RUDNICK SETH | Director | 12/10/2020 | 10,921 |
RUDNICK SETH | Director | 12/09/2020 | 117,284 |
RUDNICK SETH | Director | 12/08/2020 | 265,694 |
RUDNICK SETH | Director | 12/01/2020 | 10,449 |
MUIR GLENN P | Director | 11/18/2020 | 675,000 |
Bailey John E. (Jack) Jr. | Director | 11/11/2020 | 51,320 |
Bailey John E. (Jack) Jr. | Director | 11/10/2020 | 51,055 |
Hanson James S. | General Counsel | 09/04/2020 | 14,950 |
Moses Jennifer K. | CFO | 03/13/2020 | 7,440 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 03/13/2020 | 975 |
Velleca Mark A. | President and CEO | 03/13/2020 | 1,170 |
Velleca Mark A. | President and CEO | 01/23/2020 | 2,340 |
Moses Jennifer K. | CFO | 01/23/2020 | 3,720 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 01/23/2020 | 1,950 |
Moses Jennifer K. | CFO | 07/18/2019 | 7,440 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 01/28/2019 | 2,730 |
Moses Jennifer K. | VP of Finance | 01/17/2019 | 7,440 |
Velleca Mark A. | President and CEO | 01/17/2019 | 3,510 |
Strum Jay | Chief Scientific Officer | 01/02/2019 | 27,575 |
Hanson James S. | General Counsel | 12/26/2018 | 18,250 |
Schwalm Cynthia | Director | 12/26/2018 | 26,196 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 12/17/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 12/17/2018 | 113,280 |
Hanson James S. | General Counsel | 12/10/2018 | 32,508 |
DEMAREE JOHN | Chief Commercial Officer | 12/10/2018 | 33,151 |
Moses Jennifer K. | VP of Finance & Admin | 12/06/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 12/07/2018 | 7,440 |
Moses Jennifer K. | VP of Finance & Admin | 12/06/2018 | 25,500 |
RUDNICK SETH | Director | 12/04/2018 | 3,900 |
RUDNICK SETH | Director | 12/04/2018 | 393,146 |
MURDOCK TERRY L | SVP of Development Operations | 12/03/2018 | 47,596 |
MURDOCK TERRY L | SVP of Development Operations | 12/03/2018 | 135,779 |
PHILLIPS BARCLAY A | SVP & Chief Financial Officer | 11/15/2018 | 97,300 |
PHILLIPS BARCLAY A | SVP & Chief Financial Officer | 11/15/2018 | 199,591 |
Velleca Mark A. | President and CEO | 11/15/2018 | 18,600 |
Velleca Mark A. | President and CEO | 11/15/2018 | 199,211 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 11/15/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 11/15/2018 | 150,105 |
RUDNICK SETH | Director | 11/05/2018 | 3,900 |
RUDNICK SETH | Director | 11/05/2018 | 415,347 |
MURDOCK TERRY L | SVP of Development Operations | 11/05/2018 | 47,542 |
MURDOCK TERRY L | SVP of Development Operations | 11/05/2018 | 146,129 |
Moses Jennifer K. | VP of Finance & Admin | 11/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 11/05/2018 | 31,035 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 10/15/2018 | 18,203 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 10/15/2018 | 157,497 |
Velleca Mark A. | President and CEO | 10/15/2018 | 18,600 |
Velleca Mark A. | President and CEO | 10/11/2018 | 3,900 |
Velleca Mark A. | President and CEO | 10/15/2018 | 207,645 |
Moses Jennifer K. | VP of Finance & Admin | 10/08/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 10/08/2018 | 33,390 |
Strum Jay | Chief Scientific Officer | 10/04/2018 | 255 |
RUDNICK SETH | Director | 10/04/2018 | 3,900 |
RUDNICK SETH | Director | 10/04/2018 | 497,210 |
MURDOCK TERRY L | SVP of Development Operations | 10/03/2018 | 47,542 |
MURDOCK TERRY L | SVP of Development Operations | 10/03/2018 | 173,064 |
Velleca Mark A. | President and CEO | 09/17/2018 | 18,600 |
Velleca Mark A. | President and CEO | 09/17/2018 | 331,549 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 09/17/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 09/17/2018 | 249,502 |
Moses Jennifer K. | VP of Finance & Admin | 09/05/2018 | 7,733 |
Moses Jennifer K. | VP of Finance & Admin | 09/05/2018 | 44,700 |
RUDNICK SETH | Director | 09/04/2018 | 3,900 |
RUDNICK SETH | Director | 09/04/2018 | 599,483 |
MURDOCK TERRY L | SVP of Development Operations | 09/04/2018 | 47,542 |
MURDOCK TERRY L | SVP of Development Operations | 09/04/2018 | 211,065 |
Strum Jay | Chief Scientific Officer | 08/30/2018 | 299,876 |
Strum Jay | Chief Scientific Officer | 08/29/2018 | 296,095 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 08/15/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 08/15/2018 | 211,023 |
Velleca Mark A. | President and CEO | 08/15/2018 | 18,600 |
Velleca Mark A. | President and CEO | 08/15/2018 | 279,378 |
RUDNICK SETH | Director | 08/06/2018 | 3,900 |
RUDNICK SETH | Director | 08/06/2018 | 506,901 |
Moses Jennifer K. | VP of Finance & Admin | 08/06/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 08/06/2018 | 38,093 |
MURDOCK TERRY L | SVP of Development Operations | 08/03/2018 | 47,542 |
MURDOCK TERRY L | SVP of Development Operations | 08/03/2018 | 178,061 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 07/16/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 07/16/2018 | 159,248 |
Velleca Mark A. | President and CEO | 07/16/2018 | 18,600 |
Velleca Mark A. | President and CEO | 07/16/2018 | 210,313 |
Moses Jennifer K. | VP of Finance & Admin | 07/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 07/05/2018 | 34,245 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 06/15/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 06/15/2018 | 167,326 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 06/08/2018 | 1,638 |
Moses Jennifer K. | VP of Finance & Admin | 06/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 06/05/2018 | 29,078 |
Thorp Clay | 10% Owner | 05/30/2018 | 38,400,000 |
Velleca Mark A. | President and CEO | 05/31/2018 | 3,900 |
Thorp Clay | 10% Owner | 05/22/2018 | 300,016 |
Thorp Clay | 10% Owner | 05/21/2018 | 1,591,411 |
Thorp Clay | 10% Owner | 05/23/2018 | 25,250 |
Velleca Mark A. | President and CEO | 05/15/2018 | 27,900 |
Velleca Mark A. | President and CEO | 05/15/2018 | 347,064 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 05/15/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 05/15/2018 | 174,821 |
Moses Jennifer K. | VP of Finance & Admin | 05/07/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 05/07/2018 | 33,750 |
Velleca Mark A. | President and CEO | 04/16/2018 | 27,900 |
Velleca Mark A. | President and CEO | 04/16/2018 | 269,971 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 04/16/2018 | 15,746 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 04/16/2018 | 136,135 |
Moses Jennifer K. | VP of Finance & Admin | 04/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 04/05/2018 | 28,103 |
Velleca Mark A. | President and CEO | 03/15/2018 | 27,900 |
Velleca Mark A. | President and CEO | 03/15/2018 | 286,466 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 03/15/2018 | 3,348 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 03/15/2018 | 144,151 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 03/08/2018 | 1,638 |
Moses Jennifer K. | VP of Finance & Admin | 03/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 03/05/2018 | 19,912 |
Velleca Mark A. | President and CEO | 02/15/2018 | 27,900 |
Velleca Mark A. | President and CEO | 02/15/2018 | 150,015 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 02/15/2018 | 1,213 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 02/15/2018 | 75,520 |
Moses Jennifer K. | VP of Finance & Admin | 02/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 02/05/2018 | 17,242 |
Velleca Mark A. | President and CEO | 01/16/2018 | 27,900 |
Velleca Mark A. | President and CEO | 01/16/2018 | 172,395 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 01/16/2018 | 1,133 |
Malik Rajesh | Ch. Medical Officer & SVP R&D | 01/16/2018 | 86,693 |
Moses Jennifer K. | VP of Finance & Admin | 01/05/2018 | 292 |
Moses Jennifer K. | VP of Finance & Admin | 01/05/2018 | 14,970 |
Velleca Mark A. | President and CEO | 12/18/2017 | 27,900 |
Velleca Mark A. | President and CEO | 12/18/2017 | 150,106 |
MedImmune Ventures, Inc. | 10% Owner | 12/15/2017 | 3,950,000 |
MedImmune Ventures, Inc. | 10% Owner | 05/17/2017 | 1,125,000 |
MedImmune Ventures, Inc. | 10% Owner | 12/01/2017 | 2,644,644 |
MedImmune Ventures, Inc. | 10% Owner | 11/20/2017 | 4,002,000 |
ESHELMAN FREDRIC N | Director | 11/13/2017 | 4,932,500 |
Eshelman Ventures, LLC | 10% Owner | 05/22/2017 | 4,500,000 |
Thorp Clay | 10% Owner | 05/22/2017 | 1,999,995 |
ESHELMAN FREDRIC N | Director | 05/22/2017 | 4,500,000 |
MUIR GLENN P | Director | 05/22/2017 | 300,000 |
MedImmune Ventures, Inc. | 10% Owner | 05/22/2017 | 1,125,000 |
RA CAPITAL MANAGEMENT, LLC | Fmr 10% Owner See Footnote (2) | 05/22/2017 | 6,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
FISHER ASSET MANAGEMENT, LLC | 2,543,006 | 0.0035% | Exited | Other |
BLACKROCK INC. | 680,664 | 0.00005% | -39.24% | Other |
RENAISSANCE TECHNOLOGIES LLC | 630,400 | 0.00298% | 32.97% | Other |
D. E. SHAW & CO., INC. | 495,451 | 0.00132% | -1.91% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 460,775 | 0.00015% | 4.57% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 150,000 | 0.00095% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View